ON
← Back to feed
Truth about the breast cancer risk from your nightly glass of wine - and HRT: I'm sharing everything I've learned in 50 years of treating patients... and this is where I think we're going wrong: PROFESSOR IAN E SMITH
United Kingdom🏛️ PoliticsCenter4 hr. ago

Truth about the breast cancer risk from your nightly glass of wine - and HRT: I'm sharing everything I've learned in 50 years of treating patients... and this is where I think we're going wrong: PROFESSOR IAN E SMITH

Professor Ian E Smith, a retired cancer specialist with over 50 years of experience, reflects on advancements in breast cancer treatment and highlights ongoing challenges. He describes the stark contrast between the 1970s, when most women with breast cancer died, and today, where fewer than 30% succumb to the disease. Smith recounts his personal journey from a trainee oncologist to a leading expert, emphasizing progress through medical research and improved therapies like Herceptin. However, he also shares a poignant case involving Mrs Baker, a patient who endured severe side effects from chemotherapy, ultimately losing her quality of life. His narrative underscores both medical progress and the ethical dilemmas surrounding aggressive treatment approaches.

Go to the primary sources (1)

The official sources this coverage is built on. Read them directly to bypass framing.

1 reports

Daily Mail logoDaily MailIndependentCenter4 hr. ago
Truth about the breast cancer risk from your nightly glass of wine - and HRT: I'm sharing everything I've learned in 50 years of treating patients... and this is where I think we're going wrong: PROFESSOR IAN E SMITH

Professor Ian E Smith, a retired cancer specialist with over 50 years of experience, reflects on advancements in breast cancer treatment and highlights ongoing challenges. He describes the stark contrast between the 1970s, when most women with breast cancer died, and today, where fewer than 30% succumb to the disease. Smith recounts his personal journey from a trainee oncologist to a leading expert, emphasizing progress through medical research and improved therapies like Herceptin. However, he also shares a poignant case involving Mrs Baker, a patient who endured severe side effects from chemotherapy, ultimately losing her quality of life. His narrative underscores both medical progress and the ethical dilemmas surrounding aggressive treatment approaches.

Bias read (Center): While the article discusses medical treatment decisions and health policy implications, it does not take a clear ideological stance. The focus remains on clinical observations and patient outcomes rather than advocacy for specific political agendas. The framing is balanced, presenting both medical进步

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories